|
GOT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.988200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.837200E-01 |
| Normal-vs-Stage2 |
7.191000E-01 |
| Normal-vs-Stage3 |
7.828400E-01 |
| Normal-vs-Stage4 |
3.139200E-01 |
| Stage1-vs-Stage2 |
9.249400E-01 |
| Stage1-vs-Stage3 |
8.574800E-01 |
| Stage1-vs-Stage4 |
2.399800E-01 |
| Stage2-vs-Stage3 |
9.460600E-01 |
| Stage2-vs-Stage4 |
3.851200E-01 |
| Stage3-vs-Stage4 |
4.609800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.737400E-01 |
| Normal-vs-AfricanAmerican |
5.469000E-01 |
| Normal-vs-Asian |
5.235400E-01 |
| Caucasian-vs-AfricanAmerican |
8.034600E-01 |
| Caucasian-vs-Asian |
5.623000E-01 |
| AfricanAmerican-vs-Asian |
5.919200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.622200E-01 |
| Normal-vs-Female |
7.517400E-01 |
| Male-vs-Female |
7.338400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.614450E-01 |
| Normal-vs-Extreme_Weight |
5.924200E-01 |
| Normal-vs-Obese |
9.376400E-01 |
| Normal-vs-Extreme_Obese |
1.888180E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.150960E-01 |
| Normal_Weight-vs-Obese |
1.815240E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.476100E-02 |
| Extreme_Weight-vs-Obese |
6.997600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.030190E-01 |
| Obese-vs-Extreme_Obese |
1.983370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.969200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.099400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.362020E-01 |
| Normal-vs-Age(81-100Yrs) |
3.909400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.441400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.805200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.804000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.204600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.926400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.814750E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.561000E-01 |
| Normal-VS-Type2 PRCC |
6.874400E-01 |
| Normal-VS-KIRP CIMP |
4.725800E-01 |
| Normal-VS-Unclassified PRCC |
2.056600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.420200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.578600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.238400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.538600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.133000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.140200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.479200E-01 |
| Normal-vs-N1 |
1.265220E-01 |
| Normal-vs-N2 |
2.598100E-03 |
| N0-vs-N1 |
3.088600E-01 |
| N0-vs-N2 |
2.429800E-01 |
| N1-vs-N2 |
3.187600E-01 |
|
|
